Inhibition of Necroptosis to Prevent Long-term Cardiac Damage During Pneumococcal Pneumonia and Invasive Disease is a research paper published in The Journal of Infectious Diseases (2020). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: GM088010
National Institutes of Health
Grant: AI007051
National Institutes of Health
Grant: HL134640
National Institutes of Health
Grant: AG055144
National Institutes of Health
Grant: AI114800
American Heart Association
Grant: 16GRNT30230007
American Heart Association
Grant: 18TPA34110195
NIAID NIH HHS
Grant: T32 AI007051
NHLBI NIH HHS
Grant: T32 HL134640
NIGMS NIH HHS
Grant: K12 GM088010
NIA NIH HHS
Grant: R21 AG055144
NIAID NIH HHS
Grant: R01 AI114800
Comprehensive Cardiovascular Center
University of Alabama at Birmingham
FWCI
1.20
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Major adverse cardiovascular events are associated with necroptosis during severe COVID-19
Additional file 1 of Major adverse cardiovascular events are associated with necroptosis during severe COVID-19
Additional file 2 of Major adverse cardiovascular events are associated with necroptosis during severe COVID-19
Additional file 2 of Major adverse cardiovascular events are associated with necroptosis during severe COVID-19